← FDA DRUG APPROVALS

FDA ANDA · ANDA040273

CHLOROPROCAINE HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
ANDA040273
TYPE
ANDA
ORIGINAL APPROVAL
1998-09-09
LATEST ACTION
2010-04-07
ROUTE
EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CHLOROPROCAINE HYDROCHLORIDEPrescription
CHLOROPROCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
CHLOROPROCAINE HYDROCHLORIDEPrescription
CHLOROPROCAINE HYDROCHLORIDE 3% · INJECTABLE · INJECTION

Approval history

2010-04-07Labeling · Supplement 7AP
2001-04-03Manufacturing (CMC) · Supplement 1AP
1998-09-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →